{"data":{"id":"us/21-cfr-211.87","jurisdiction":"us","citation":"21 CFR 211.87","heading":"Retesting of approved components, drug product containers, and closures.","body":"Components, drug product containers, and closures shall be retested or reexamined, as appropriate, for identity, strength, quality, and purity and approved or rejected by the quality control unit in accordance with § 211.84 as necessary, e.g., after storage for long periods or after exposure to air, heat or other conditions that might adversely affect the component, drug product container, or closure.","path":["Title 21—Food and Drugs","CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES","SUBCHAPTER C—DRUGS: GENERAL","PART 211—CURRENT GOOD MANUFACTURING PRACTICE FOR FINISHED PHARMACEUTICALS","Subpart E—Control of Components and Drug Product Containers and Closures"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-21.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:24:47Z","sha256":"d00f0e0aeceaece455192035060dd681cdd6af38127ad7283219fea3c031611b","source_id":"us-cfr","stale":true,"prev":"us/21-cfr-211.86","next":"us/21-cfr-211.89"},"notice":"GroundRules: Original legal text. Not legal advice."}